Perspective Therapeutics
CATX
28 hedge funds and large institutions have $5.49M invested in Perspective Therapeutics in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 5 closing their positions.
197% more capital inflows, than outflows
Capital inflows: $1.03M | Capital outflows: $347K
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
4% more funds holding
Funds holding: 27 → 28 (+1)
0.73% more ownership
Funds ownership: 6.12% → 6.86% (+0.73%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bridgeway Capital Management
Houston,
Texas
|
+$238K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$233K |
| 3 |
Morgan Stanley
New York
|
+$203K |
| 4 |
Millennium Management
New York
|
+$119K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$76.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$104K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$84K |
| 3 |
Invesco
Atlanta,
Georgia
|
-$49K |
| 4 |
Virtu KCG Holdings
New York
|
-$45.2K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$22K |
CATX Hedge Fund Activity: Q4 2014 in Review
28 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q4 2014, worth a combined $5.49M — down 2.5% from $5.63M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CATX positions and 5 closed out — a net gain of 2 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Bridgeway Capital Management, opening a new position worth an estimated $238K. The largest seller was Goldman Sachs, cutting an estimated $104K.
- 28 institutional investors held Perspective Therapeutics (CATX) as of Q4 2014, up from 27 in Q3 2014.
- Funds reported $5.49M of Perspective Therapeutics stock for Q4 2014, down 2.5% quarter-over-quarter.
- 7 funds opened new Perspective Therapeutics positions in Q4 2014 and 5 closed out, a net change of +2 holders.
- The largest Perspective Therapeutics buyer in Q4 2014 was Bridgeway Capital Management, an estimated $238K added.
- The largest Perspective Therapeutics seller in Q4 2014 was Goldman Sachs, an estimated $104K sold.
Based on aggregated 13F filings for Q4 2014.